Get started today and save with Zolpimist

Eligible patients pay as little as $30 on your Zolpimist Prescription

To help make Zolpimist more affordable, we’ve created the Zolpimist Savings Program. By accessing this offer, eligible patients can pay as little as $30 on your Zolpimist prescription or refill.* To get started, simply click on the “GET YOUR CARD” button below.

GET YOUR CARD

Need help with your Prescription?

In addition to our copay savings program, we also provide another important benefit – unparalleled patient support. Through ZolpimistDIRECT, you will have access to significant advantages. Ask your Doctor about enrolling you in ZolpimistDIRECT.

*ELIGIBILITY AND RESTRICTIONS

On each valid ZolpiMistTM prescription or refill, pay as low as $30 copay on all prescriptions, maximum benefits apply per use, for up to 12 refills. Patient is responsible for any remaining balance, and for reporting receipt of this coupon benefit to any insurer, health plan, or other third party who pay for or reimburses any part of the prescription filled using the coupon, as may be required. Patient, pharmacist, and prescriber agree not to seek reimbursement for all or any part of the benefit received by the patient through this offer. Offer only valid for patients over age 18 who have private health insurance. Offer not valid for uninsured patients or for patients eligible for Medicaid, Medicare, TRICARE, Veterans Affairs or any other state or federal healthcare program (including state prescription drug programs). Offer good only in the USA and void where prohibited by law, taxed, or restricted. Aytu BioScience reserves the right to rescind, revoke, or amend this offer without notice. Card is limited to one per person, is not transferrable and cannot be reproduced.

openArrow

Zolpimist (zolpidem tartrate) Oral Spray, a gamma-aminobutyic acid (GABA) A agonist, is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate has been shown to decrease the time it takes to fall asleep for up to 35 days in controlled clinical studies.

Important Safety Information

READ MORE

Zolpimist (zolpidem tartrate) Oral Spray, a gamma-aminobutyic acid (GABA) A agonist, is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate has been shown to decrease the time it takes to fall asleep for up to 35 days in controlled clinical studies.

Important Safety Information

download

Zolpimist (zolpidem tartrate) Oral Spray, a gamma-aminobutyic acid (GABA) A agonist, is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate has been shown to decrease the time it takes to fall asleep for up to 35 days in controlled clinical studies.

.

Important Safety Information

.

Zolpimist is indicated for the short-term treatment of insomnia.

.

When you first start taking Zolpimist and until you know how you will react to this medication, use caution in the morning when you engage in activities requiring complete alertness. In most instances, memory problems can be avoided if you take Zolpimist only when you can sleep full night (e.g., 7 to 8 hours) before your planned awakening time. As with any sleep medication, do not use alcohol while you are taking Zolpimist. Tell your provider about all your health conditions and all the medicines you take, including prescriptions, nonprescriptions, and dietary supplements.

.

Sleepwalking, eating, or driving while not fully awake, without memory of the event, and rare incidents of allergic reactions, have been reported. If you have any of these experiences, contact your provider immediately.

.

Prescription sleep medicines are often taken for 7 to 10 days, perhaps longer if prescribed by your provider. Like many sleep aids, Zolpimist has some risk for dependency.

.

With short-term use, Zolpimist has a low incidence of side effects. In clinical trials, the most commonly reported side effects were drowsiness (2%), dizziness (1%), and diarrhea (1%).

.

The recommended initial Zolpimist dosage for women and elderly persons is 5 mg, for men 5 mg or 10 mg, immediately before bedtime, with at least 7 -8 hours remaining before the planned time of awakening.

.

To report suspected adverse events or product complaints, please email Aytu BioScience at zolpimist@aytubio.com; FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.